Search Log In

fig1

From:  Biomarkers in anderson-Fabry disease: what should we use in the clinical practice?
Biomarkers in anderson-Fabry disease: what should we use in the clinical practice?

Figure 1. Plasma lyso-Gb3: sub-analysis by gender in male and female patients with Fabry disease[46]. Lyso-Gb3: Globotriaosylsphingosine.

Rare Disease and Orphan Drugs Journal
ISSN 2771-2893 (Online)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://publicationethics.org/members/rare-disease-and-orphan-drugs-journal

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://publicationethics.org/members/rare-disease-and-orphan-drugs-journal

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/
partners@oaepublish.com Company Contact Us
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2024 OAE Publishing Inc., except certain content provided by third parties